5-Minute Clinical Update and Grand Rounds with Dr. Thomas McGinn

Learning Objectives: Define the key pharmacologic therapies for HFrEH and HFpEF and describe their optimal use in specific patient population Discuss the barriers and the necessary resources required for successful rapid up-titration of GDMT Identify how improvement in medical therapy influences patient outcomes, including hospitalizations, re-admissions, and mortality Speakers: Biykem Bozkurt, MD...

Guests: Dr. Ankita Sagar, System VP for Clinical Standards and Variation Reduction and Dr. Suchitra Pilli, Interventional Pulonologist and Critical Care, Creighton University School of Medicine Discussed: updated lung cancer screening guidelines including the move to risk-based screening, screening criteria recommendations, integrating the criteria into the process of care, and follow-up to positi...

Learning Objectives: - Define the clinical definition of HFrEF, HFmidREF, and HFpEF - Describe the current epidemiology, economic burden, and quality standards - Explain the underlying pathophysiology of HFrEF and HFpEF with associated signs and symptoms Speakers: Ajith P. Nair, MD, FACC, FAHA, Assistant Professor, Cardiology, Baylor College of Medicine Nikolaos A. Diakos, MD, PhD, Interventional...

In this 5-minute check in we're reviewing how CommonSpirit has created streamlined preventative screening algorithms for lung, breast, and colon cancer. Issues addressed include:  - Updated and simplified guidelines: changes we've made using best available evidence          - Combining USPSTF and NCCN          - Why we're shifting from age- to risk-based screening - Future state: cl...

Learning Objectives: Discuss updates in medical weight loss Identify ongoing barriers to weight loss management Speakers: Layla A. Abushamat, MD, MPH, Assistant Professor, Baylor College of Medicine Mahmuda Tasneem, MD, Internal Medicine and Obesity Medicine, Virginia Mason Franciscan Health Panelists: Anila Chadha, MD, Obesity Medicine Specialist, Dignity Health Medical Group — Bakersfield Thu Le...

The FDA has approved the first cell-based gene therapies for sickle cell disease. In this extended episode, Dr. McGinn is joined by Creighton Geneticist and Bioethicist Fr. Kevin FitzGerald and Dr. Ankita Sagar, System Vice President for Clinical Standards and Variation Reduction, to dive into this significant milestone. Together they discuss CRISPR technology, treatment strategies, bioethics, and...

Guest: Dr. Christopher Huerter, Professor and Division Chief Dermatology at Creighton University School of Medicine Breakthrough treatments: Checkpoint inhibitors like Ipilimumab have changed the way we treat melanoma. Now, a new cutting-edge adoptive cell therapy with tumor-infiltrating lymphocytes (TIL) has shown promise in metastatic melanoma treatment trials. A new phase III trial compares TIL...

Learning Objectives: Promoting evidence-based cancer screening and prevention strategies Understanding risk factors related to eligibility for lung cancer screening Identifying the key aspects of a successful lung cancer screening program Recognizing the ways in which technology can be leveraged for identifying patients eligible for lung cancer screening Speakers: Suchitra Pilli, MD , Pulmonary Me...

What does the winter virus season have in store? Dr. McGinn and Dr. Vivekanandan (Division Chief, Infectious Disease and Professor at Creighton School of Medicine) look at the winter virus trends including where we currently are and what to expect this season with COVID, Influenza, RSV and pneumonia. They also discuss the so-called "White Lung" syndrome, a recent pneumonia outbreak makin...

Dr. Thomas McGinn and cardiac electrophysiology expert Dr. Arash Aryana focus on afib and the use of ablation, including a new randomized controlled trial that compares the success of Pulmonary Vein Isolation (PVI) against PVI plus Posterior Wall Isolation (PWI) using the posterior "Box" isolation approach. Dr. McGinn and Dr. Aryana discuss:  PVI vs. PVI + PWI and whether there is a sign...

Learning Objectives: -Promoting evidence-based cancer screening and prevention strategies -Discerning between patients with average, below average, and above average risk -Recognizing the differences between modalities available for colorectal cancer screening Speakers: -Devi Mukkai Krishnamurty, MBBS, Colorectal Surgery, General Surgery, CHI Health Omaha Nebraska -Ron Gagliano, MD, Colorectal Sur...

Learning Objectives: Promoting evidence-based cancer screening and prevention strategies Discerning between patients with average, below average, and above average risk Recognizing the differences between imaging modalities available for breast cancer screening Speakers: Jessica Croley, MD , Breast Medical Oncologist, OCI Breast Clinical Council Lead Peter Eby, MD , FSBI, FACR, Section Head of Bre...

Myth vs. Fact: New series on mythbusting, comparing the culture of medicine with the evidence.  Dr. Thomas McGinn and Dr. Ankita Sagar, System VP for Clinical Standards and Variation Reduction, tackle two commonly held beliefs and compare them to the data:  1) Statins and whether they cause muscle aches  2) Fasting before labs

New Guidelines for Asthma Management and Changes in Biologics featuring Dr. Rajan Merchant, Allergy, Asthma, and Clinical Immunology Specialist at Woodland Clinic. Discussed: 1) key recommendations for primary care from the Global Initiative for Asthma (GINA) update and 2) S.M.A.R.T. (Single Maintenance and Reliever Therapy 3) Biologics Articles referenced:  https://www.nature.com/articles/s41533-...

Learning Objectives: Review best practices in screening for suicidal ideation Illustrate strategies for addressing suicidality in primary care using standard suicide risk scales Speaker: Jonathan DeHaan, MD, Psychiatry, Virginia Mason Franciscan Health Medical Group Andrew Trindle, LICSW, Manager, Outpatient Behavioral Health, Virginia Mason Hospital and Seattle Medical Center

Learning Objectives: - Describe the epidemiology of depression among adults - Discuss the assessment of depression among adults - Enumerate the treatments for depression among adults Speakers: Rajesh Tampi, MD, Professor and Chairman, Department of Psychiatry, Bhatia Family Endowed Chair in Psychiatry, Creighton University School of Medicine Panelists: Debra Rockman, RN, MBA, CPHRM, CPHQ,  System...

Learning Objectives: - Review best practices in screening and diagnosis - Illustrate treatment strategies - Identify and strategize to overcome common challenges Speaker: Jyotsna Ranga, MD, FAPA, DFAACAP, Associate Professor of Medicine at Creighton University School of Medicine, Program Director of Psychiatry Residency and Child/Adolescent Fellowship Programs at Creighton University, Vice Chair C...

Dr. Vivekanandan and Dr. Hotez join Dr. McGinn for a deep dive discussion on RSV including vaccine strategy; options for infants, pregnant women and seniors; benefits vs. risks; and why people who qualify should get the RSV vaccine.  Guests:  Dr. Renuga Vivekanandan, Division Chief, Infectious Disease, Creighton School of Medicine  Dr. Peter Hotez, Professor and Dean National School of Tropical Me...

FDA says Popular Decongestant is Ineffective and the Impact of Coffee on Arrhythmia  Guest: Dr. Kavita Chawla, Chair - EBM Education Committee, Internal Medicine, Virginia Mason Franciscan Health Articles referenced:  https://www.nejm.org/doi/full/10.1056/NEJMoa2204737 In this 5-minute check in, Dr. McGinn and guest Dr. Kavita Chawla review two health care topics making headlines:  An F.D.A. panel...

Dr. Thomas McGinn discusses what to expect for Fall viruses and their respective vaccinations this year.

Discusses appropriate use of pronouns and terminology to be utilized in communication with members of the LGBTQ+ community in an inclusive and equitable manner, in keeping with the values and ethics of health care delivery. Speakers: Dr. Mark Goodman, Creighton University School of Medicine, American Academy of HIV Medicine Specialist Dr. Michael A. Green, Program Director, Creighton University, D...

Guests: Dr. Ankita Sagar, System VP for Clinical Standards and Variation Reduction, Physician Enterprise and Dr. Nick Stine, System SVP Population Health, Physician Enterprise. Overview: Screening and Treatment of Hepatitis C. CommonSpirit Health is pioneering clinical standards in the treatment of Hepatitis C to ensure our physicians and APPs are equipped with the necessary tools to identify and...

This session will encompass an overview of the management of Hepatitis C in primary care and subspecialty medicine. Dr. Justin Reynolds will review the basic principles of managing Hepatitis C, screening methodologies for advanced fibrosis in Hepatitis C patients, and the framework for initiating treatment with direct-acting antiviral (DAA) regimens. Dr. Saira Khaderi will present insights into th...

The objectives of the presentation include: By the end of the presentation, participants will be able to compare and contrast oral and injectable forms of pre-exposure prophylaxis (PrEP) for HIV prevention, identifying their respective safety profiles, efficacy, and potential advantages or limitations. Following the presentation, participants will be able to discuss the importance of medication ad...

Can AI like Chat GPT guide clinical decision making and does it have a place in clinical practice? In this 5-minute check in, Dr. McGinn, Dr. Gary Greensweig and Dr. Ankita Sagar run three different case studies with strong evidence for diagnosis and therapeutic intervention through Chat GPT and reviewed the results. Watch the 5-minute check in to see whether Chat GPT was helpful and might have op...